Search information
enGene Holdings Inc.
Companies
"Benefits"
Keywords
Tables in SEC filings
Source
January 31, | October 31, | |||||||
2024 | 2023 | |||||||
Accrued research and development expenses | $ | 1,473 | $ | 759 | ||||
Professional fees | 2,143 | 1,708 | ||||||
Employee compensation and related benefits | 1,555 | 814 | ||||||
Accrued income tax payable | 9 | 39 | ||||||
Other | 57 | 219 | ||||||
Total accrued expenses and other current liabilities | $ | 5,237 | $ | 3,539 |